title: Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy.
abstract: Prostate cancer (CaP) is the most commonly diagnosed cancer in males. There have been dramatic technical advances in radiotherapy delivery, enabling higher doses of radiotherapy to primary cancer, involved lymph nodes and oligometastases with acceptable normal tissue toxicity. Despite this, many patients relapse following primary radical therapy, and novel treatment approaches are required. Metal nanoparticles are agents that promise to improve diagnostic imaging and image-guided radiotherapy and to selectively enhance radiotherapy effectiveness in CaP. We summarize current radiotherapy treatment approaches for CaP and consider pre-clinical and clinical evidence for metal nanoparticles in this condition.
authors.affiliation: 1 School of Pharmacy, McClay Research Centre, Queen's University Belfast, Belfast, UK.
authors.forename: J A
authors.initials: JA
authors.lastname: Coulter
authors.affiliation: 2 Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
authors.forename: K T
authors.initials: KT
authors.lastname: Butterworth
authors.affiliation: 2 Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
authors.forename: S
authors.initials: S
authors.lastname: Jain
mesh_terms: D003952:Diagnostic Imaging / Q000379:methods*; D006801:Humans; D008297:Male; D053768:Metal Nanoparticles / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000532:radiotherapy*